218 related articles for article (PubMed ID: 32909511)
1. Trimetazidine can prevent the occurrence of contrast-induced nephropathy after percutaneous coronary intervention in elderly patients with renal insufficiency.
Fu H; Zhang J; Zhang H; Zhang P; Fu X; Zeng Z; Zhang X; Li W; Yang S; Liu X; Fu N
Perfusion; 2021 Sep; 36(6):603-609. PubMed ID: 32909511
[TBL] [Abstract][Full Text] [Related]
2. Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study.
Chen F; Liu F; Lu J; Yang X; Xiao B; Jin Y; Zhang J
Eur J Med Res; 2018 May; 23(1):23. PubMed ID: 29776437
[TBL] [Abstract][Full Text] [Related]
3. Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease.
Ibrahim TA; El-Mawardy RH; El-Serafy AS; El-Fekky EM
Cardiovasc Revasc Med; 2017; 18(5):315-319. PubMed ID: 28532702
[TBL] [Abstract][Full Text] [Related]
4. Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: A systematic review and meta-analysis (PRISMA).
Heshmatzadeh Behzadi A; Amoozgar B; Jain S; Velasco N; Zahid U; Abbasi H; Alasadi L; Prince MR
Medicine (Baltimore); 2021 Mar; 100(10):e24603. PubMed ID: 33725824
[TBL] [Abstract][Full Text] [Related]
5. Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention.
Shehata M
Am J Cardiol; 2014 Aug; 114(3):389-94. PubMed ID: 24927970
[TBL] [Abstract][Full Text] [Related]
6. Trimetazidine Prevention of Contrast-Induced Nephropathy in Coronary Angiography.
Liu W; Ming Q; Shen J; Wei Y; Li W; Chen W; Xu Y
Am J Med Sci; 2015 Nov; 350(5):398-402. PubMed ID: 26445302
[TBL] [Abstract][Full Text] [Related]
7. Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis.
Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
Medicine (Baltimore); 2017 Mar; 96(9):e6059. PubMed ID: 28248861
[TBL] [Abstract][Full Text] [Related]
8. The effect of trimetazidine on contrast-induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention - A systematic review and meta-analysis.
Martha JW; Pranata R; Wibowo A; Irvan I; Afrianti R; Akbar MR
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):3045-3053. PubMed ID: 33877668
[TBL] [Abstract][Full Text] [Related]
9. Preventive effect of trimetazidine on contrast-induced nephropathy undergoing percutaneous coronary intervention in elderly moderate and high risk diabetics stratified by mehran score.
Zhang X; Zhang P; Yang S; Li W; Men X; Fu N
Perfusion; 2021 Jul; 36(5):491-500. PubMed ID: 32838661
[TBL] [Abstract][Full Text] [Related]
10. Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency.
Ye Z; Lu H; Su Q; Xian X; Li L
Oncotarget; 2017 Nov; 8(60):102521-102530. PubMed ID: 29254267
[TBL] [Abstract][Full Text] [Related]
11. Preventive Effects of Nicorandil Against Contrast-Induced Nephropathy in Patients With Moderate Renal Insufficiency Undergoing Percutaneous Coronary Intervention.
Zhang P; Li WY; Yang SC; Fu NK; Liu XG; Zhang X; Cong HL; Lin WH; Tian FS; Lu CZ; Zhang J
Angiology; 2020 Feb; 71(2):183-188. PubMed ID: 30987432
[TBL] [Abstract][Full Text] [Related]
12. Trimetazidine Decreases Risk of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials.
Nadkarni GN; Konstantinidis I; Patel A; Yacoub R; Kumbala D; Patel RA; Annapureddy N; Pakanati KC; Simoes PK; Javed F; Benjo AM
J Cardiovasc Pharmacol Ther; 2015 Nov; 20(6):539-46. PubMed ID: 25715308
[TBL] [Abstract][Full Text] [Related]
13. Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.
Onbasili AO; Yeniceriglu Y; Agaoglu P; Karul A; Tekten T; Akar H; Discigil G
Heart; 2007 Jun; 93(6):698-702. PubMed ID: 17065180
[TBL] [Abstract][Full Text] [Related]
14. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
[TBL] [Abstract][Full Text] [Related]
15. Preventive Effects of Alprostadil Against Contrast-Induced Nephropathy Inpatients With Renal Insufficiency Undergoing Percutaneous Coronary Intervention.
Yang SC; Fu NK; Zhang J; Liang M; Cong HL; Lin WH; Tian FS; Lu CZ; Sun TT; Zhang WY; Ma ZH
Angiology; 2018 May; 69(5):393-399. PubMed ID: 29073785
[TBL] [Abstract][Full Text] [Related]
16. The effect of trimetazidine on preventing contrast-induced nephropathy after cardiac catheterization.
Lian X; He W; Zhan H; Chen J; Tan N; He P; Liu Y
Int Urol Nephrol; 2019 Dec; 51(12):2267-2272. PubMed ID: 31641999
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
Liang M; Yang S; Fu N; Lu C; Tian F; Xing X; Lin W; Liu J
Catheter Cardiovasc Interv; 2018 Mar; 91(4):742-750. PubMed ID: 29024304
[TBL] [Abstract][Full Text] [Related]
18. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
[TBL] [Abstract][Full Text] [Related]
20. Effect of Vigileo/FloTrac System-Guided Aggressive Hydration in Acute Myocardial Infarction Patients to Prevent Contrast-Induced Nephropathy After Urgent Percutaneous Coronary Intervention.
Ling W; Jiang Z; Liu K; Zhang H; Qian Y; Tian J; Zhang Z; Chen Y; Qian G
Am J Cardiol; 2023 May; 195():77-82. PubMed ID: 37018968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
